Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
36.7M
-
Shares change
-
-41K
-
Total reported value, excl. options
-
$1.79B
-
Value change
-
-$17.7M
-
Put/Call ratio
-
0.59
-
Number of buys
-
78
-
Number of sells
-
-53
-
Price
-
$48.86
Significant Holders of MYOKARDIA INC - COM (MYOK) as of Q4 2018
158 filings reported holding MYOK - MYOKARDIA INC - COM as of Q4 2018.
MYOKARDIA INC - COM (MYOK) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.7M shares
.
Largest 10 shareholders include FMR LLC (6.04M shares), Vanguard Group Inc (3.06M shares), BlackRock Inc. (2.86M shares), WELLINGTON MANAGEMENT GROUP LLP (2.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.48M shares), FARALLON CAPITAL MANAGEMENT LLC (1.6M shares), Partner Fund Management, L.P. (1.54M shares), PERCEPTIVE ADVISORS LLC (1.08M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (997K shares), and BB BIOTECH AG (877K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.